Company Profile
Pediatrix Medical Group, Inc. Stock Price, News & Analysis
Company overview
Business overview
Pediatrix Medical Group is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Pediatrix Medical Group is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Business Model Characteristics
Pediatrix Medical Group makes its case through product adoption, operating discipline, and the pace at which the installed base turns into recurring revenue.
Position Within the Biotechnology Landscape
Compared with drug-development peers, Pediatrix Medical Group trades more like a product-adoption story, where reimbursement, procedure volume, and refresh cycles matter more than a single clinical binary.
Why the stock is moving
MD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Pediatrix Medical Group's catalysts are newborn-care volumes, reimbursement, and labor execution in a physician-services business that moves more on operations than on pipeline headlines. The next update matters if it shows the care-delivery base is stable enough to support margin recovery and a cleaner growth profile.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Pediatrix Medical Group Announces $250 Million Share Repurchase Program
Source: Pediatrix Medical Group, Inc.
- 02
Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025
Source: Pediatrix Medical Group, Inc.
- 03
Pediatrix Medical Group Reports Third Quarter Results
Source: Pediatrix Medical Group, Inc.
- 04
Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026
Source: Pediatrix Medical Group, Inc.
- 05
Pediatrix Medical Group Reports Fourth Quarter Results
Source: Pediatrix Medical Group, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.